Spontaneous Lesions in Aging FVB/N Mice

Abstract

The FVB/N mouse strain was created in the early 1970s and has since been used extensively in transgenic research because of its well-defined inbred background, superior reproductive performance, and prominent pronuclei of fertilized zygotes, which facilitate microinjection of DNA. Little is known, however, about the survivability and spontaneous disease of nontransgenic FVB/N mice. Therefore, the purpose of this study was to determine survival to 24 mo of age and the incidence of neoplastic and nonneoplastic disease at 14 and 24 mo of age. At 14 mo of age, the incidence of tumor-bearing mice was 13% in males (n = 45) and 26% in females (n = 98). All tumors in males and most in females at this time were alveolar-bronchiolar (AB) neoplasms of the lung. Survival to 24 mo of age was approximately 60% in both sexes (29/50 males, 71/116 females), and the incidence of mice with tumors at this time was 55% in males and 66% in females. In decreasing order of frequency, the following neoplasms were observed in >5% of subjects: in males, lung AB tumors, liver hepatocellular tumors, subcutis neural crest tumors, and Harderian gland adenomas; in females, lung AB tumors, pituitary gland adenomas, ovarian tumors (combined types), lymphomas, histiocytic sarcomas, Harderian gland adenomas, and pheochromocytomas. Compared with other mouse strains, the observed incidences of tumors in FVB/N mice suggest a higher than usual rate of lung tumors and a lower than usual incidence of liver tumors and lymphomas. This tumor profile should be considered in the interpretation of neoplastic phenotypes in FVB/N-derived transgenic lines.

Keywords

Tumors mouse spontaneous transgenic

References

Brinster RL , Chen HY , Trumbauer ME , Yagle MK , and Palmiter RD (1985). Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA 82: 4438-4442.

Cuthbertson RA and Klintworth GK (1988). Transgenic mice-A gold mine for furthering knowledge in pathobiology. Lab. Invest . 58: 484-502.

Drinkwater NR and Ginsler JJ (1986). Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 7: 1701-1707.

Elwell MR , Stedham MA , and Kovatch RM (1990). Skin and subcutis. In: Pathology of the Fischer Rat, GA Boorman , SL Eustis , MR Elwell , CA Montgomery , and WF MacKenzie (eds). Academic Press , San Diego, pp. 261-277.

Frith CH (1996). Histology, adrenal gland, mouse. In: Monographs on Pathology of Laboratory Animals-Endocrine System, TC Jones , CC Capen , and U Mohr (eds). Springer-Verlag, Berlin, pp. 386-391.

Frith CH (1996). Lipogenic pigmentation, adrenal cortex, mouse . In: Monographs on Pathology of Laboratory Animals-Endocrine System, TC Jones , CC Capen , and U Mohr (eds). Springer-Verlag, Berlin , pp. 458-462.

Frith CH , Ward JM , and Chandra M. (1993). The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol. Pathol . 21: 206-218.

Haseman JK and Johnson FM (1996). Analysis of National Toxicology Program rodent bioassay data for anticarcinogenic effects. Mutation Res. 350: 131-141.

Hennings H. , Glick AB , Lowry DT , Krsmanovic LS , Sly LM , and Yuspa SH (1993). FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14: 2353-2358.

10.

Leder A. , Kuo A. , Cardiff RD , Sinn E. , and Leder P. (1990). v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87: 9178-9182.

11.

Mahler JF , Mann P. , Takaoka M. , and Maronpot RR (1995). Spontaneous lesions of the FVB/N mouse. Toxicol. Pathol. 23: 744-745.

12.

Muller WJ , Sinn E. , Pattengale PK , Wallace R. , and Leder P. (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115.

13.

Overbeek PA (1994). Factors affecting transgenic animal production . In: Transgenic Animal Technology, CA Pinkert (ed). Academic Press, San Diego, pp. 69-114.

14.

Polites HG and Pinkert CA (1994). DNA microinjection and transgenic animal production . In: Transgenic Animal Technology, CA Pinkert (ed). Academic Press, San Diego, p. 15.

15.

Rittinghausen S. , Dungworth DL , Ernst H. , and Mohr U. (1996). Naturally occurring pulmonary tumors in rodents. In: Monographs on Pathology of Laboratory Animals-Respiratory System, TC Jones , DL Dungworth , and U Mohr (eds). Springer-Verlag, Berlin . pp. 183-206.

16.

Schulz N. , Propst F. , Rosenber MP , Linnoila RI , Paules RS , Kovatch R. , Ogiso Y. , and Van de Woude G. (1992). Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: A model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res. 52: 450-455.

17.

Sinn E. , Muller W. , Pattengale P. , Tepler I. , Wallace R. , and Leder P. (1987). Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell 49: 465-475.

18.

Stewart TA , Pattengale PK , and Leder P. (1984). Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627-637.

19.

Sztein JM and Raber JM (1994). Genital abnormalities in a mouse. Lab. Anim. 23: 19-21.

20.

Taketo M. , Schroeder AC , Mobraaten LE , Gunning KB , Hanten G. , Fox RR , Roderick TH , Stewart CL , Lilly F. , Hansen CT , and Overbeek PA (1991). FVB/N: An inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. USA 88: 2065-2069.

21.

Turusov VS (1994). Histiocytic sarcoma. In: Pathology of Tumours in Laboratory Animals, Volume 2-Tumours of the Mouse, V Turusov and U Mohr (eds). IARC Publications, Lyon , pp. 671-680.